SUNZEN BIOTECH BHD

KLSE (MYR): SUNZEN (0148)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.315

Today's Change

-0.005 (1.56%)

Day's Change

0.31 - 0.32

Trading Volume

126,100

Financial

Show?
Last 10 FY Result
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 91,856 96,871 142,699 0 97,103 90,444 82,233 239,864 300,429 303,451 40,013 32,221 19.12%
PBT 3,440 9,624 15,686 0 7,348 3,730 -12,704 -20,557 -6,941 4,012 -455 -259 -
Tax -2,436 -3,325 -5,251 0 -2,695 -1,765 -209 1,401 4 -372 395 -88 61.73%
NP 1,004 6,299 10,435 0 4,653 1,965 -12,913 -19,156 -6,937 3,640 -60 -347 -
-
NP to SH 1,928 5,966 9,172 0 3,636 698 -13,231 -17,460 -6,870 3,474 -130 -348 -
-
Tax Rate 70.81% 34.55% 33.48% - 36.68% 47.32% - - - 9.27% - - -
Total Cost 90,852 90,572 132,264 0 92,450 88,479 95,146 259,020 307,366 299,811 40,073 32,568 17.91%
-
Net Worth 141,637 141,637 141,158 120,335 120,335 96,958 89,890 89,758 101,148 100,837 89,722 52,200 12.40%
Dividend
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Div - - - - - - - - - 1,440 - - -
Div Payout % - - - - - - - - - 41.47% - - -
Equity
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Net Worth 141,637 141,637 141,158 120,335 120,335 96,958 89,890 89,758 101,148 100,837 89,722 52,200 12.40%
NOSH 734,468 734,468 728,480 707,854 720,540 625,462 535,046 535,046 525,195 482,318 479,124 290,000 11.43%
Ratio Analysis
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 1.09% 6.50% 7.31% 0.00% 4.79% 2.17% -15.70% -7.99% -2.31% 1.20% -0.15% -1.08% -
ROE 1.36% 4.21% 6.50% 0.00% 3.02% 0.72% -14.72% -19.45% -6.79% 3.45% -0.14% -0.67% -
Per Share
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 12.97 13.68 20.22 0.00 13.72 15.86 15.55 45.43 59.40 63.20 8.92 11.11 7.29%
EPS 0.28 0.84 1.30 0.00 0.51 0.12 -2.50 -3.31 -1.36 0.72 -0.03 -0.12 -
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.30 0.00 0.00 -
NAPS 0.20 0.20 0.20 0.17 0.17 0.17 0.17 0.17 0.20 0.21 0.20 0.18 1.24%
Adjusted Per Share Value based on latest NOSH - 734,468
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
RPS 11.41 12.03 17.72 0.00 12.06 11.23 10.21 29.79 37.31 37.69 4.97 4.00 19.12%
EPS 0.24 0.74 1.14 0.00 0.45 0.09 -1.64 -2.17 -0.85 0.43 -0.02 -0.04 -
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.18 0.00 0.00 -
NAPS 0.1759 0.1759 0.1753 0.1494 0.1494 0.1204 0.1116 0.1115 0.1256 0.1252 0.1114 0.0648 12.41%
Price Multiplier on Financial Quarter End Date
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 30/09/24 30/09/24 28/06/24 30/06/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 -
Price 0.34 0.34 0.35 0.21 0.20 0.25 0.18 0.105 0.165 0.31 0.205 0.42 -
P/RPS 2.62 2.49 1.73 0.00 1.46 1.58 1.16 0.23 0.28 0.49 2.30 3.78 -8.78%
P/EPS 124.89 40.36 26.93 0.00 38.94 204.28 -7.19 -3.18 -12.15 42.85 -707.43 -350.00 -
EY 0.80 2.48 3.71 0.00 2.57 0.49 -13.90 -31.49 -8.23 2.33 -0.14 -0.29 -
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.97 0.00 0.00 -
P/NAPS 1.70 1.70 1.75 1.24 1.18 1.47 1.06 0.62 0.83 1.48 1.03 2.33 -3.31%
Price Multiplier on Announcement Date
AQR T4Q 30/06/24 30/06/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Date 22/11/24 22/11/24 29/08/24 - 23/02/23 25/02/22 25/02/21 27/02/20 28/02/19 27/02/18 28/02/17 25/02/16 -
Price 0.315 0.315 0.315 0.00 0.205 0.265 0.19 0.10 0.175 0.275 0.29 0.33 -
P/RPS 2.43 2.30 1.56 0.00 1.49 1.67 1.22 0.22 0.29 0.44 3.25 2.97 -7.29%
P/EPS 115.70 37.39 24.24 0.00 39.91 216.54 -7.59 -3.02 -12.88 38.01 -1,000.76 -275.00 -
EY 0.86 2.67 4.13 0.00 2.51 0.46 -13.17 -33.07 -7.76 2.63 -0.10 -0.36 -
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.09 0.00 0.00 -
P/NAPS 1.57 1.57 1.57 0.00 1.21 1.56 1.12 0.59 0.88 1.31 1.45 1.83 -1.78%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
5 people like this. Showing 50 of 2,230 comments

gloveshapiro

0.31-0.32 is a steady & cheap entry price now, Sunzen entering the healthcare sector will push the price further up

2024-08-08 15:07

VeneerWood

Just keep accumulating if you have extra bullets

2024-08-08 15:56

GGstarz

hidden star of 2024 ni, test 0.34 resistance next week

2024-08-09 15:51

03zerothreee

Strong growth every quarter, Sunzen future prospect is really bright with new acquisition

2024-08-09 16:10

RamsyNa

Sunzen's returns on capital are heading higher. Buy & hold it for long run

2024-08-09 16:11

Wixson

Its ROCE is around 8.1% if using FY2023 figures

2024-08-09 19:23

emptech

slow week ahead before result is out end of this month

2024-08-12 15:54

VeneerWood

No worries, it's a sign of quiet before the storm 😬

2024-08-12 16:24

ameeya13

biotech industry having positive growth, good QR for Sunzen for sure!

2024-08-12 16:30

Wixson

Next quarter's revenue and net profit will both increase quarter-on-quarter and year-on-year, I believe

2024-08-12 20:08

nbatofu

0.31 is cheapest price now, sunzen stay strong

2024-08-13 15:55

RamsyNa

Sunzen has decreased current liabilities to 6.3% of total assets over this period. Good sign

2024-08-13 16:15

gloveshapiro

nice... entering into healthcare sector is a correct decision

2024-08-13 16:19

VeneerWood

Worth to invest it for long term 🤝

2024-08-13 17:36

Rose001

Post removed.Why?

2024-09-23 08:20

GregBursa

I just watched it. Must say the new management seems to be doing the right thing compare to the previous one. At least now SUNZEN is no longer losing money but making profit

2024-09-23 10:20

Greenbull88

Sunzen will be one of the best performing stock in year 2025

2 months ago

jaynetan

I joined

2 months ago

Greenbull88

Hopes the Xmegami lenglui will buy in sunzen also since their earning so high every month

2 months ago

Greenbull88

China market so bullish, hopes Sunzen main export to China will benefit

2 months ago

GregBursa

Watched the technical analysis here https://youtu.be/9V0_mkxG1sw?si=M-l0iuIJeU4w9q5Q

2 months ago

mf

Dow Jones

Dow Jones Industrial Average

42,011.59

-184.93

0.43%

Nasdaq

NASDAQ Composite

17,918.47

-6.64

0.03%

2 months ago

Greenbull88

Hearsay sunzen will hit RM1 in 2025

2 months ago

biggie0000

director dispose...

1 month ago

Wixson

Share price still steady after that, biggie0000. We wait for the next rally to come

1 month ago

Greenbull88

Good company and will be jackpot in 2025

1 month ago

RamsyNa

As consumers pay more and more attention to preventive health care and natural remedies, Sunzen's traditional Chinese medicine and human health supplement products have huge growth potential

1 month ago

gloveshapiro

Re-enter 0.315, Sunzen Q3 will back above 2m profit again

1 month ago

VeneerWood

Nice grab, gloveshapiro. If the QR is good as expected, it probably will break 35 cents

1 month ago

ameeya13

0.31-0.32 is a nice entry price, better buy while sunzen is consolidating

1 month ago

RamsyNa

SUNZEN-WC is nice too. Premium is 0 😁

1 month ago

emptech

Sunzen Biotech eyes bigger share of China bird’s nest market. Sunzen subsidiary Ecolite Biotech Manufacturing Sdn Bhd has received approval from China’s customs authority in October last year to export its bottled bird’s nest to the country up to 2028.

1 month ago

Wixson

The demand for edible bird’s nest products is indeed strong in China, Hong Kong, and other parts of Southeast Asia. The Chinese market, in particular, is one of the largest consumers of bird’s nests, driven by a cultural preference for traditional health products and rising disposable incomes

1 month ago

GGstarz

non-stop expansion & acquisition, Sunzen slow & steady je

1 month ago

ameeya13

biotech industry is slowing growing, end of nov qr should see some improvement

1 month ago

VeneerWood

Sunzen's loan financing business is expected to continue to grow given the increasing trend in the number of applications and approvals, mainly due to our ability to provide fast and efficient services and structure more flexible loan packages to meet the needs of the SME market.

1 month ago

nbatofu

Acquisition of Eye Nation Medical is expected to contribute positively to the future financial performance of the Sunzen group, enhancing the group’s revenue and profitability, as it is secured by a profit guarantee of an audited profit after tax of RM2.60 million over the next two financial years

1 month ago

RamsyNa

Then SUNZEN will be able to achieve over RM1 million of net profit in the next quarter 😀

1 month ago

03zerothreee

more expansion into the healthcare sector, Sunzen keep building & growing... TP 0.40

4 weeks ago

Wixson

QR was out, the company reported revenue of RM22.96 million and PBT of RM0.86 million. In the current quarter, human health products and loan financing accounted for 76.85% and 14.26%, respectively, while the remaining 8.89% came from the animal health business.

3 weeks ago

03zerothreee

result not bad, Sunzen might see some breakout this week

3 weeks ago

Yi Long Mask

Many new ID created and comment here....Power

3 weeks ago

GGstarz

why so sour, eye nation & ecolite biotech will start bringin in more profit next quarter

3 weeks ago

VeneerWood

Tell that to yourself, Yi Long Mask or Elon Musk 😂

3 weeks ago

Wixson

Some are investors of SUNZEN here, some are bystanders like E Long Mess. ha

3 weeks ago

03zerothreee

SUNZEN-WC is a good buy now, keep monitor

3 weeks ago

RamsyNa

Malaysia is one of the world’s largest producers of bird’s nest, with a significant portion of its production exported to China, where demand remains robust. Maintain a "buy" rating on Sunzen

2 weeks ago

GGstarz

Sunzen healthcare products are slow & steady, next resistance 0.34

2 weeks ago

nbatofu

double down on SUNZEN, TP 0.35 for me

2 weeks ago

biggie0000

SUNZEN GROUP BERHAD SEES SHAREHOLDERS SUPPORT IN AGM WITH APPROVAL IN ALL 9 RESOLUTIONS

1 day ago

Post a Comment